Brasure M, MacDonald R, Dahm P, Olson CM, Nelson VA, Fink HA et al. Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Review. May 2016. (AHRQ Comparative Effectiveness Reviews; Volume 178).
Favilla V, Russo GI, Privitera S, Castelli T, Giardina R, Calogero AE et al. Impact of combination therapy 5-alpha reductase inhibitors (5-ARI) plus alpha-blockers (AB) on erectile dysfunction and decrease of libido in patients with LUTS/BPH: a systematic review with meta-analysis. Aging Male 2016; 19(3): 175-181.
National Clinical Guideline Centre. The Management of Lower Urinary Tract Symptoms in Men. 2010. (NICE Clinical Guidelines; Volume 97).
Wu YJ, Dong Q, Liu LR, Wei Q. A meta-analysis of efficacy and safety of the new alpha1A-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH. Prostate Cancer Prostatic Dis 2013; 16(1): 79-84.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.